[HTML][HTML] Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors

HJG Abrahams, MFM Gielissen, IC Schmits… - Annals of …, 2016 - Elsevier
Background This meta-analysis aimed to (i) examine demographic, disease-related, and
treatment-related risk factors,(ii) estimate the prevalence, and (iii) describe the course of …

Epigenetic therapeutics: a new weapon in the war against cancer

N Ahuja, AR Sharma, SB Baylin - Annual review of medicine, 2016 - annualreviews.org
The past 15 years have seen an explosion of discoveries related to the cellular regulation of
phenotypes through epigenetic mechanisms. This regulation provides a software that …

[HTML][HTML] Causes of death among cancer patients

NG Zaorsky, TM Churilla, BL Egleston, SG Fisher… - Annals of oncology, 2017 - Elsevier
Background The purpose of our study was to characterize the causes of death among
cancer patients as a function of objectives:(i) calendar year,(ii) patient age, and (iii) time after …

A multifunctional nanovaccine based on L‐arginine‐loaded black mesoporous titania: ultrasound‐triggered synergistic cancer sonodynamic therapy/gas therapy …

M Wang, Z Hou, S Liu, S Liang, B Ding, Y Zhao… - Small, 2021 - Wiley Online Library
In order to achieve better antitumor therapeutic efficacy and inhibit tumor metastasis, a
multifunctional nanovaccine based on L‐arginine (LA)‐loaded black mesoporous titania …

Precision oncology: The UC San Diego moores cancer center predict experience

M Schwaederle, BA Parker, RB Schwab… - Molecular cancer …, 2016 - AACR
By profiling their patients' tumors, oncologists now have the option to use molecular results
to match patients with drug (s) based on specific biomarkers. In this observational study, 347 …

Generation of BiKEs and TriKEs to improve NK cell-mediated targeting of tumor cells

M Felices, TR Lenvik, ZB Davis, JS Miller… - Natural Killer Cells …, 2016 - Springer
Cancer immunotherapies have gained significant momentum over the past decade,
particularly with the advent of checkpoint inhibitors and CAR T-cells. While the latter …

[HTML][HTML] MicroRNAs in serum exosomes as potential biomarkers in clear-cell renal cell carcinoma

W Zhang, M Ni, Y Su, H Wang, S Zhu, A Zhao… - European urology focus, 2018 - Elsevier
Abstract Background Circulating microRNAs (miRNAs) in exosomes are emerging as
clinically useful tools for cancer detection. However, little is known about their diagnostic …

Natural killer cells unleashed: checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy

ZB Davis, DA Vallera, JS Miller, M Felices - Seminars in Immunology, 2017 - Elsevier
Natural killer (NK) cells have long been known to mediate anti-tumor responses without prior
sensitization or recognition of specific tumor antigens. However, the tumor microenvironment …

Critical care of patients with cancer

A Shimabukuro‐Vornhagen, B Boell… - CA: a cancer journal …, 2016 - Wiley Online Library
Answer questions and earn CME/CNE The increasing prevalence of patients living with
cancer in conjunction with the rapid progress in cancer therapy will lead to a growing …

Spiro-oxindoles as a promising class of small molecule inhibitors of p53–MDM2 interaction useful in targeted cancer therapy

AK Gupta, M Bharadwaj, A Kumar… - Topics in Current …, 2017 - Springer
As a result of the toxicity of currently available anticancer drugs and the inefficiency of
chemotherapeutic treatments, the design and discovery of effective and selective antitumor …